000			01513 a2200421 4500
005			20250513144523.0
264		0	_c19980708
008			199807s 0 0 eng d
022			_a0041-1345
024	7		_a10.1016/s0041-1345(98)00173-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aUndre, N A
245	0	0	_aPharmacokinetics of tacrolimus (FK506) in primary orthotopic heart transplant patients. _h[electronic resource]
260			_bTransplantation proceedings _cJun 1998
300			_a1112-5 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
650	0	4	_aAdult
650	0	4	_aChromatography, High Pressure Liquid
650	0	4	_aCyclosporine _xadverse effects
650	0	4	_aEnzyme-Linked Immunosorbent Assay
650	0	4	_aFemale
650	0	4	_aHeart Transplantation _ximmunology
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xadverse effects
650	0	4	_aMale
650	0	4	_aMass Spectrometry
650	0	4	_aMetabolic Clearance Rate
650	0	4	_aRegression Analysis
650	0	4	_aTacrolimus _xadverse effects
700	1		_aMeiser, B M
700	1		_aUberfuhr, P
700	1		_aReichart, B
700	1		_aStevenson, P
700	1		_aSchäfer, A
700	1		_aMöller, A
773	0		_tTransplantation proceedings _gvol. 30 _gno. 4 _gp. 1112-5
856	4	0	_uhttps://doi.org/10.1016/s0041-1345(98)00173-0 _zAvailable from publisher's website
999			_c9602731 _d9602731